Symptom provocation studies in psychiatric disorders: scientific value, risks, and future-Reference-Cited by-同舟云学术

Symptom provocation studies in psychiatric disorders: scientific value, risks, and future

Published:1999-10 Issue:8 Volume:46 Page:1060-1080
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

D’Souza D.Cyril,Berman Robert M,Krystal John H,Charney Dennis S

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference153 articles.

1. The conjunctival provocation test model of ocular allergy;Abelson;Ocular Pharmacol Ther,1998

2. Increased striatal dopamine transmission in schizophrenia;Abi-Dargham;Am J Psychiatry,1998

3. Anand A, Charney DS, Cappiello A, Berman RM, Oren DA, Krystal JH (1997) Lamotrigine reduces the psychotomimetic but not the mood-elevating effects of ketamine in humans. 36th Annual Meeting, American College of Neuropsychopharmacology, pp 251.

4. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics;Anden;Eur J Pharmacol,1970

5. Symptoms, signs, and diagnosis of schizophrenia;Andreasen;Lancet,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward personalized circuit-based closed-loop brain-interventions in psychiatry: using symptom provocation to extract EEG-markers of brain circuit activity;Frontiers in Neural Circuits;2023-08-21

2. Canalization and plasticity in psychopathology;Neuropharmacology;2023-03

3. The early identification of psychosis: can lessons be learnt from cardiac stress testing?;Psychopharmacology;2015-11-14

4. There is more than the amygdala: Potential threat assessment in the cingulate cortex;Neuroscience & Biobehavioral Reviews;2011-03

5. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis;Journal of Psychopharmacology;2009-03-20